Bank of New York Mellon’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.53M | Buy |
291,203
+1,969
| +0.7% | +$70.9K | ﹤0.01% | 2056 |
|
|
2026
Q1 | $10.2M | Buy |
289,234
+4,309
| +2% | +$175K | ﹤0.01% | 1922 |
|
|
2025
Q4 | $11.6M | Buy |
284,925
+9,559
| +3% | +$416K | ﹤0.01% | 1852 |
|
|
2025
Q3 | $13M | Sell |
275,366
-14,899
| -5% | -$772K | ﹤0.01% | 1789 |
|
|
2025
Q2 | $15.1M | Buy |
290,265
+1,072
| +0.4% | +$58.8K | ﹤0.01% | 1668 |
|
|
2025
Q1 | $17.5M | Sell |
289,193
-29,030
| -9% | -$1.87M | ﹤0.01% | 1568 |
|
|
2024
Q4 | $21.8M | Buy |
318,223
+48,907
| +18% | +$3.41M | ﹤0.01% | 1518 |
|
|
2024
Q3 | $19.4M | Sell |
269,316
-28,863
| -10% | -$2.04M | ﹤0.01% | 1594 |
|
|
2024
Q2 | $20.7M | Sell |
298,179
-1,775
| -0.6% | -$129K | ﹤0.01% | 1561 |
|
|
2024
Q1 | $24M | Sell |
299,954
-113,906
| -28% | -$10.2M | ﹤0.01% | 1473 |
|
|
2023
Q4 | $45.3M | Sell |
413,860
-14,764
| -3% | -$1.53M | 0.01% | 1099 |
|
|
2023
Q3 | $43.2M | Sell |
428,624
-66,825
| -13% | -$7.68M | 0.01% | 1082 |
|
|
2023
Q2 | $67.3M | Buy |
495,449
+133,543
| +37% | +$16.3M | 0.01% | 841 |
|
|
2023
Q1 | $37.6M | Sell |
361,906
-2,474
| -0.7% | -$239K | 0.01% | 1178 |
|
|
2022
Q4 | $32.3M | Buy |
364,380
+5,508
| +2% | +$457K | 0.01% | 1264 |
|
|
2022
Q3 | $28.8M | Buy |
358,872
+15,915
| +5% | +$1.5M | 0.01% | 1271 |
|
|
2022
Q2 | $32.8M | Sell |
342,957
-7,669
| -2% | -$920K | 0.01% | 1238 |
|
|
2022
Q1 | $52.1M | Buy |
350,626
+575
| +0.2% | +$80.3K | 0.01% | 1064 |
|
|
2021
Q4 | $49.6M | Buy |
350,051
+20,431
| +6% | +$2.89M | 0.01% | 1173 |
|
|
2021
Q3 | $43.1M | Buy |
329,620
+11,915
| +4% | +$1.56M | 0.01% | 1231 |
|
|
2021
Q2 | $43.7M | Sell |
317,705
-3,523
| -1% | -$482K | 0.01% | 1227 |
|
|
2021
Q1 | $41.9M | Sell |
321,228
-10
| -0% | -$1.2K | 0.01% | 1225 |
|
|
2020
Q4 | $36M | Sell |
321,238
-7,306
| -2% | -$692K | 0.01% | 1263 |
|
|
2020
Q3 | $25.8M | Sell |
328,544
-2,504
| -0.8% | -$204K | 0.01% | 1304 |
|
|
2020
Q2 | $23.8M | Buy |
331,048
+14,256
| +5% | +$992K | 0.01% | 1340 |
|
|
2020
Q1 | $18.1M | Sell |
316,792
-19,291
| -6% | -$1.78M | 0.01% | 1349 |
|
|
2019
Q4 | $37.6M | Sell |
336,083
-67,511
| -17% | -$7.19M | 0.01% | 1161 |
|
|
2019
Q3 | $38.8M | Buy |
403,594
+17,832
| +5% | +$1.67M | 0.01% | 1103 |
|
|
2019
Q2 | $33M | Sell |
385,762
-104,609
| -21% | -$8.6M | 0.01% | 1239 |
|
|
2019
Q1 | $40.8M | Buy |
490,371
+94,729
| +24% | +$6.88M | 0.01% | 1098 |
|
|
2018
Q4 | $25.4M | Sell |
395,642
-26,245
| -6% | -$1.8M | 0.01% | 1318 |
|
|
2018
Q3 | $33.4M | Buy |
421,887
+17,851
| +4% | +$1.38M | 0.01% | 1295 |
|
|
2018
Q2 | $29.6M | Buy |
404,036
+3,964
| +1% | +$270K | 0.01% | 1356 |
|
|
2018
Q1 | $25.3M | Buy |
400,072
+17,055
| +4% | +$1.02M | 0.01% | 1421 |
|
|
2017
Q4 | $19.5M | Sell |
383,017
-17,757
| -4% | -$925K | 0.01% | 1574 |
|
|
2017
Q3 | $21M | Sell |
400,774
-13,901
| -3% | -$698K | 0.01% | 1524 |
|
|
2017
Q2 | $21.1M | Sell |
414,675
-4,861
| -1% | -$240K | 0.01% | 1523 |
|
|
2017
Q1 | $18.6M | Buy |
419,536
+18,243
| +5% | +$785K | 0.01% | 1597 |
|
|
2016
Q4 | $17.7M | Buy |
401,293
+40,070
| +11% | +$1.7M | 0.01% | 1615 |
|
|
2016
Q3 | $14.5M | Buy |
361,223
+1,351
| +0.4% | +$57.4K | ﹤0.01% | 1660 |
|
|
2016
Q2 | $17.2M | Sell |
359,872
-22,901
| -6% | -$970K | 0.01% | 1497 |
|
|
2016
Q1 | $16.1M | Buy |
382,773
+3,889
| +1% | +$153K | ﹤0.01% | 1557 |
|
|
2015
Q4 | $16.7M | Sell |
378,884
-9,518
| -2% | -$413K | 0.01% | 1509 |
|
|
2015
Q3 | $18.5M | Buy |
388,402
+43,291
| +13% | +$2.38M | 0.01% | 1463 |
|
|
2015
Q2 | $20.1M | Buy |
345,111
+7,568
| +2% | +$408K | 0.01% | 1487 |
|
|
2015
Q1 | $17M | Sell |
337,543
-102,547
| -23% | -$5.03M | ﹤0.01% | 1616 |
|
|
2014
Q4 | $19.8M | Sell |
440,090
-17,827
| -4% | -$747K | 0.01% | 1470 |
|
|
2014
Q3 | $16.9M | Sell |
457,917
-10,811
| -2% | -$429K | ﹤0.01% | 1560 |
|
|
2014
Q2 | $20.7M | Buy |
468,728
+11,310
| +2% | +$513K | 0.01% | 1452 |
|
|
2014
Q1 | $19.9M | Buy |
457,418
+112,594
| +33% | +$5.02M | 0.01% | 1456 |
|
|
2013
Q4 | $14.7M | Sell |
344,824
-2,514
| -0.7% | -$95.5K | ﹤0.01% | 1659 |
|
|
2013
Q3 | $11.8M | Buy |
347,338
+9,216
| +3% | +$301K | ﹤0.01% | 1740 |
|
|
2013
Q2 | $10.6M | Buy |
+338,122
| New | +$11M | ﹤0.01% | 1756 |
|
Other funds holding CNMD
CB
GT
TCM
Bank of New York Mellon's CNMD Position: Q2 2026 in Review
Bank of New York Mellon increased its CONMED (CNMD) stake by 0.68% in Q2 2026, buying an estimated $70.9K and bringing the position to 291,203 shares worth $9.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2056.
Bank of New York Mellon first reported a position in CNMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $67.3M in Q2 2023. 122 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Bank of New York Mellon held 291,203 shares of CONMED worth $9.53M as of Q2 2026.
- Bank of New York Mellon bought 1,969 CONMED shares in Q2 2026, an estimated $70.9K.
- CONMED made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2056 holding.
- Bank of New York Mellon first reported a position in CONMED in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's CONMED position peaked at $67.3M in Q2 2023.
- 122 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.